US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Regentis Biomaterials Ltd.

1.75

-0.0500-2.78%

Pre-market: 1.750.00000.00%07:41 EDT

Volume:20.61K

Turnover:37.84K

Market Cap:12.31M

PE:-0.66

High:1.87

Open:1.82

Low:1.75

Close:1.80

52wk High:15.50

52wk Low:1.23

Shares:7.04M

Float Shares:4.84M

Volume Ratio:0.38

T/O Rate:0.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.6440

EPS(LYR):-24.1600

ROE:--

ROA:-113.59%

PB:1.60

PE(LYR):-0.07

Loading ...

Overview Company News Filings

Regentis Biomaterials (NYSE American: RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant

Regentis Biomaterials Sets July 2, 2026 AGM to Vote on Director Incentives, Compensation Policy and Auditor

Regentis Biomaterials announces annual shareholder meeting

Regentis Biomaterials (NYSE American: RGNT) Is ‘One to Watch’

Regentis Biomaterials (NYSE American: RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair

NYSE American New 52-Week Highs And Lows

Amex Halt Add Info Lst 2.730000

THOMSON REUTERS

Regentis Biomaterials enters collaboration with Humanitas Research Hospital

Regentis Biomaterials files Form 3 for Chief Medical Officer Galit Reske

Regentis Biomaterials Director Keith Valentine Files Initial Beneficial Ownership Statement

Regentis Biomaterials Ltd. CEO Ehud Geller files initial beneficial ownership statement

Regentis Biomaterials Director Susan Alpert filed initial beneficial ownership statement

Regentis Biomaterials Director Efraim Cohen-Arazi Files Initial Beneficial Ownership Statement

Regentis Biomaterials director Jeff Dykan files initial beneficial ownership statement

Regentis Biomaterials CFO Gon Ori files initial beneficial ownership statement

Regentis Biomaterials Ltd. files Form 3 as Chief Accounting Officer Arie Gordashnikov reports no beneficial ownership

Regentis Biomaterials Director Pini Ben-Elazar Files Initial Beneficial Ownership Statement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/RGNT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"RGNT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGNT\",,,,,undefined,":{"symbol":"RGNT","market":"US","secType":"STK","nameCN":"Regentis Biomaterials Ltd.","latestPrice":1.75,"timestamp":1789675200000,"preClose":1.8,"halted":0,"volume":20607,"hourTrading":{"tag":"盘前","latestPrice":1.75,"preClose":1.75,"latestTime":"07:41 EDT","volume":767,"amount":1346.6296467,"timestamp":1789731683988,"change":0,"changeRate":0,"amplitude":0.074114},"delay":0,"changeRate":-0.0277777777777778,"floatShares":4842164,"shares":7036500,"eps":-2.644,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"09-18 08:48:53 EDT","open":1.82,"high":1.87,"low":1.75,"amount":37843.5087765,"amplitude":0.066667,"askPrice":2,"askSize":100,"bidPrice":1.72,"bidSize":6,"shortable":3,"etf":0,"ttmEps":-2.644,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":1,"adr":0,"listingDate":1764824400000,"exchange":"AMEX","adjPreClose":1.75,"preHourTrading":{"tag":"盘前","latestPrice":1.75,"preClose":1.75,"latestTime":"07:41 EDT","volume":767,"amount":1346.6296467,"timestamp":1789731683988,"change":0,"changeRate":0,"amplitude":0.074114},"postHourTrading":{"tag":"盘后","latestPrice":1.75,"preClose":1.75,"latestTime":"18:58 EDT","volume":11,"amount":19.55,"timestamp":1789685885250,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.3814105173609786},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RGNT\",,,,,undefined,":{"symbol":"RGNT","floatShares":4842164,"roa":"-113.59%","roe":"--","lyrEps":-24.159999,"volumeRatio":0.3814105173609786,"shares":7036500,"dividePrice":0,"high":1.87,"amplitude":0.066667,"preClose":1.8,"low":1.75,"week52Low":1.2316,"pbRate":"1.60","week52High":15.5,"institutionHeld":0,"latestPrice":1.75,"committee":-0.886792,"eps":-2.644,"divideRate":0,"volume":20607,"delay":0,"ttmEps":-2.644,"open":1.82,"prevYearClose":6.74,"prevWeekClose":1.89,"prevMonthClose":2.04,"prevQuarterClose":3.53,"fiveDayClose":1.96,"twentyDayClose":2.23,"sixtyDayClose":4.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RGNT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RGNT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RGNT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RGNT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RGNT","date":"2026-09-17","current":-0.661876,"percent":0.625,"low":-9.624274,"twenty":-5.72734,"median":-1.176441,"eighty":-0.765066,"high":11.294138,"avg":-2.217539,"sd":3.411197,"marketCap":12643057},"quantilePoints":[{"date":"2025-09-12","current":11.294138,"twenty":11.294138,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-09-17","current":11.294138,"twenty":11.294138,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-14","current":-9.624274,"twenty":-1.256909,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-20","current":-9.624274,"twenty":-9.624274,"median":11.294138,"eighty":11.294138,"marketCap":54223158},{"date":"2025-11-26","current":-9.624274,"twenty":-9.624274,"median":-9.624274,"eighty":11.294138,"marketCap":54223158},{"date":"2025-12-05","current":-6.894806,"twenty":-9.624274,"median":-7.354459,"eighty":11.294138,"marketCap":38845335},{"date":"2025-12-12","current":-6.563855,"twenty":-9.624274,"median":-6.89021,"eighty":11.294138,"marketCap":36980758},{"date":"2025-12-19","current":-5.880074,"twenty":-9.624274,"median":-6.600627,"eighty":11.294138,"marketCap":33128337},{"date":"2025-12-26","current":-6.113394,"twenty":-9.624274,"median":-6.527083,"eighty":1.180569,"marketCap":34442863},{"date":"2026-01-02","current":-6.196132,"twenty":-8.716348,"median":-6.3708,"eighty":-5.580196,"marketCap":34909007},{"date":"2026-01-09","current":-6.352414,"twenty":-7.170598,"median":-6.31555,"eighty":-5.626198,"marketCap":35789501},{"date":"2026-01-16","current":-7.078667,"twenty":-7.005123,"median":-6.260483,"eighty":-5.72734,"marketCap":39881210},{"date":"2026-01-23","current":-6.664979,"twenty":-6.894806,"median":-6.333844,"eighty":-5.846096,"marketCap":37550490},{"date":"2026-01-30","current":-5.635354,"twenty":-6.892967,"median":-6.278869,"eighty":-5.846096,"marketCap":31749587},{"date":"2026-02-06","current":-4.421869,"twenty":-6.856195,"median":-6.196132,"eighty":-5.571003,"marketCap":24912808},{"date":"2026-02-13","current":-4.026566,"twenty":-6.723814,"median":-6.113762,"eighty":-5.331983,"marketCap":22685675},{"date":"2026-02-20","current":-3.594492,"twenty":-6.664979,"median":-6.113394,"eighty":-4.421869,"marketCap":20251367},{"date":"2026-02-27","current":-1.495219,"twenty":-6.600627,"median":-6.113394,"eighty":-4.026566,"marketCap":20406749},{"date":"2026-03-06","current":-1.271316,"twenty":-6.563855,"median":-6.053639,"eighty":-3.612878,"marketCap":17350916},{"date":"2026-03-13","current":-1.282663,"twenty":-6.527083,"median":-5.880074,"eighty":-1.504175,"marketCap":17505779},{"date":"2026-03-20","current":-1.196479,"twenty":-6.527083,"median":-5.644593,"eighty":-1.282663,"marketCap":16329542},{"date":"2026-03-27","current":-1.153672,"twenty":-6.526991,"median":-5.56181,"eighty":-1.271316,"marketCap":15745309},{"date":"2026-04-02","current":-1.138492,"twenty":-6.505001,"median":-5.341176,"eighty":-1.230216,"marketCap":15538134},{"date":"2026-04-10","current":-1.159364,"twenty":-6.396541,"median":-4.971155,"eighty":-1.194415,"marketCap":15822999},{"date":"2026-04-17","current":-1.214391,"twenty":-6.356091,"median":-4.421869,"eighty":-1.179477,"marketCap":16574009},{"date":"2026-04-24","current":-1.168851,"twenty":-6.34506,"median":-4.136653,"eighty":-1.176433,"marketCap":15952484},{"date":"2026-05-01","current":-1.104337,"twenty":-6.335719,"median":-3.755371,"eighty":-1.159364,"marketCap":15071989},{"date":"2026-05-08","current":-0.865254,"twenty":-6.326637,"median":-3.645054,"eighty":-1.156707,"marketCap":11808981},{"date":"2026-05-15","current":-0.777969,"twenty":-6.302772,"median":-3.401437,"eighty":-1.138492,"marketCap":10617724},{"date":"2026-05-22","current":-0.815919,"twenty":-6.267838,"median":-1.499697,"eighty":-1.134697,"marketCap":11135662},{"date":"2026-05-29","current":-0.751404,"twenty":-6.243936,"median":-1.282663,"eighty":-1.110409,"marketCap":10255168},{"date":"2026-06-05","current":-0.652735,"twenty":-6.210841,"median":-1.277843,"eighty":-0.952538,"marketCap":8908530},{"date":"2026-06-12","current":-0.721045,"twenty":-6.196132,"median":-1.273213,"eighty":-0.865254,"marketCap":9840818},{"date":"2026-06-18","current":-1.802612,"twenty":-6.163331,"median":-1.275111,"eighty":-0.865254,"marketCap":24602045},{"date":"2026-06-26","current":-1.574913,"twenty":-6.113836,"median":-1.282663,"eighty":-0.878916,"marketCap":21494418},{"date":"2026-07-02","current":-1.734302,"twenty":-6.113394,"median":-1.282663,"eighty":-0.902444,"marketCap":23669757},{"date":"2026-07-10","current":-1.38137,"twenty":-6.113394,"median":-1.369985,"eighty":-0.917624,"marketCap":18852935},{"date":"2026-07-17","current":-0.842484,"twenty":-6.113394,"median":-1.339625,"eighty":-0.916106,"marketCap":11498219},{"date":"2026-07-24","current":-0.74002,"twenty":-6.113394,"median":-1.282663,"eighty":-0.865254,"marketCap":10099787},{"date":"2026-07-31","current":-0.683095,"twenty":-6.113394,"median":-1.280253,"eighty":-0.838689,"marketCap":9322880},{"date":"2026-08-07","current":-0.747609,"twenty":-6.102271,"median":-1.275111,"eighty":-0.81535,"marketCap":10203374},{"date":"2026-08-14","current":-0.721045,"twenty":-6.085815,"median":-1.256325,"eighty":-0.781764,"marketCap":9840818},{"date":"2026-08-21","current":-0.781764,"twenty":-6.021463,"median":-1.222019,"eighty":-0.777969,"marketCap":10669518},{"date":"2026-08-28","current":-0.781764,"twenty":-5.92034,"median":-1.201659,"eighty":-0.779867,"marketCap":10669518},{"date":"2026-09-04","current":-0.747609,"twenty":-5.880074,"median":-1.193519,"eighty":-0.774174,"marketCap":10203374},{"date":"2026-09-11","current":-0.743814,"twenty":-5.846096,"median":-1.180236,"eighty":-0.76962,"marketCap":10151580},{"date":"2026-09-17","current":-0.971049,"twenty":-5.72734,"median":-1.176441,"eighty":-0.765066,"marketCap":12643057}],"updateTime":1789735733867},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RGNT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2639804671","title":"Regentis Biomaterials (NYSE American: RGNT) Targets Major Gap in Knee Cartilage Repair Market with Off-the-Shelf Regenerative Implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2639804671","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639804671?lang=en_us&edition=fundamental","pubTime":"2026-05-30 01:00","pubTimestamp":1780074008,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, May 29th, 2026, FinanceWire Regentis Biomaterials Ltd. (NYSE American: RGNT) is advancing GelrinC(R), a cell-free hyd...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-targets-major-gap-in-knee-cartilage-repair-market-with-off-the-shelf-regenerative-implant?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-targets-major-gap-in-knee-cartilage-repair-market-with-off-the-shelf-regenerative-implant?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4232","NYSE","R","BK4139","BK4107","BK4117","AFG","BK4022","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639117786","title":"Regentis Biomaterials Sets July 2, 2026 AGM to Vote on Director Incentives, Compensation Policy and Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2639117786","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639117786?lang=en_us&edition=fundamental","pubTime":"2026-05-29 05:45","pubTimestamp":1780004731,"startTime":"0","endTime":"0","summary":"The latest update is out from Regentis Biomaterials Ltd ( ($RGNT) ). On May 28, 2026, Regentis Biomaterials announced it will hold its Annual Gener...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-sets-july-2-2026-agm-to-vote-on-director-incentives-compensation-policy-and-auditor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regentis-biomaterials-sets-july-2-2026-agm-to-vote-on-director-incentives-compensation-policy-and-auditor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4229","BK4195","RGNT","AGM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639619163","title":"Regentis Biomaterials announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639619163","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639619163?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:46","pubTimestamp":1780001218,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials will hold its annual general meeting in Tel Aviv, Israel on July 2, 2026.Shareholders will vote on the re-election of Class I directors Ehud Geller, Efraim Cohen-Arazi.Resolutions cover equity awards, including director option grants at a US$ 2.16 exercise price, a top-up option grant for Pini Ben-Elazar.Proposals also include issuing replacement warrants to certain lenders, including warrants for Ehud Geller, Jeff Dykan at an exercise price of NIS 0.01.Items include adopting a compensation policy, reappointing Deloitte Israel as independent auditor for the year ending Dec. 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL6PdMGQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639690892","title":"Regentis Biomaterials (NYSE American: RGNT) Is ‘One to Watch’","url":"https://stock-news.laohu8.com/highlight/detail?id=2639690892","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639690892?lang=en_us&edition=fundamental","pubTime":"2026-05-29 01:00","pubTimestamp":1779987614,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, May 28th, 2026, FinanceWire GelrinC(R) is positioned as a potential first-in-class, off-the-shelf solution for knee c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-is-one-to-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-is-one-to-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4022","BK4232","RGNT","BK4107","BK4117","NYSE","AFG","BK4139","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638549139","title":"Regentis Biomaterials (NYSE American: RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair","url":"https://stock-news.laohu8.com/highlight/detail?id=2638549139","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638549139?lang=en_us&edition=fundamental","pubTime":"2026-05-27 00:30","pubTimestamp":1779813007,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, May 26th, 2026, FinanceWire Approximately 472,500 arthroscopic knee procedures in the U.S. each year involve cartilag...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-and-the-off-the-shelf-opportunity-in-knee-cartilage-repair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/regentis-biomaterials-nyse-american-rgnt-and-the-off-the-shelf-opportunity-in-knee-cartilage-repair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNT","BK4117","AFG","BK4107","BK4139","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632895949","title":"NYSE American New 52-Week Highs And Lows","url":"https://stock-news.laohu8.com/highlight/detail?id=2632895949","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632895949?lang=en_us&edition=fundamental","pubTime":"2026-05-04 22:21","pubTimestamp":1777904460,"startTime":"0","endTime":"0","summary":"COMPANY                      SYMBOL       HIGH         VOLUME. -------                      ------       ----         ------. abrdn EM ex-China Fd         AEF          9.31         20,598. Bancroft Fund                BCV         24.68          3,700. Ellsworth Growth & Incm      ECF         12.75         13,847. OptimumBank Holdings         OPHC         5.60          5,488. COMPANY                      SYMBOL       LOW          VOLUME. -------                      ------       ----         ------. CEL-SCI                      CVM          1.72        401,173. Regentis Biomaterials        RGNT         2.40          7,385. Copyright (c) 2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4117","BK4107","AFG","BK4139","NYSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629842971","title":"Amex Halt  Add Info Lst 2.730000","url":"https://stock-news.laohu8.com/highlight/detail?id=2629842971","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629842971?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:37","pubTimestamp":1777037838,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nAQN2LW0E5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627215368","title":"Regentis Biomaterials enters collaboration with Humanitas Research Hospital","url":"https://stock-news.laohu8.com/highlight/detail?id=2627215368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627215368?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:51","pubTimestamp":1776343882,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials (RGNT) announced a collaboration with Humanitas Research Hospital in Milan, Italy,. This collaboration is currently in the pr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-enters-collaboration-with-humanitas-research-hospital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regentis-biomaterials-enters-collaboration-with-humanitas-research-hospital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623324566","title":"Regentis Biomaterials files Form 3 for Chief Medical Officer Galit Reske","url":"https://stock-news.laohu8.com/highlight/detail?id=2623324566","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623324566?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:32","pubTimestamp":1774906347,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials Chief Medical Officer Galit Reske reported holding employee stock options for 67,961 shares at a $4 exercise price in an initial beneficial ownership filing dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLTbmpD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620779262","title":"Regentis Biomaterials Director Keith Valentine Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620779262","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620779262?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:32","pubTimestamp":1773865930,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials reported an initial statement of beneficial ownership by director Keith Valentine. Keith Valentine disclosed an employee stock option for 37,500 shares of common stock. The option has an exercise price of USD 1.46 and an expiration date of Jan. 9, 2029.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9nb7C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262032","title":"Regentis Biomaterials Ltd. CEO Ehud Geller files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262032","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262032?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:32","pubTimestamp":1773865927,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials reported an initial statement of beneficial ownership by Ehud Geller, a director and chief executive officer. The filing reported employee stock options covering 182,000 shares with an exercise price of USD 0.01. It also reported employee stock options covering 283,533 shares with an exercise price of USD 0.01. The filing reported warrants to purchase 92,821 shares with an exercise price of USD 5.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL6v6vCG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262722","title":"Regentis Biomaterials Director Susan Alpert filed initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262722","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262722?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:32","pubTimestamp":1773865920,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials reported an initial statement of beneficial ownership filed by Susan Alpert. Susan Alpert is listed as a director. The filing stated that Susan Alpert beneficially owned no securities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL5BWfJM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262772","title":"Regentis Biomaterials Director Efraim Cohen-Arazi Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262772","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262772?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:31","pubTimestamp":1773865882,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials filed an initial statement of beneficial ownership on behalf of Efraim Cohen-Arazi. He is listed as a director. The filing stated that no securities are beneficially owned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL4HkFBl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262701","title":"Regentis Biomaterials director Jeff Dykan files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262701","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262701?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:31","pubTimestamp":1773865881,"startTime":"0","endTime":"0","summary":"Jeff Dykan, a director of Regentis Biomaterials, filed an initial statement of beneficial ownership. The filing reported indirect beneficial ownership of 270,473 ordinary shares. It also reported indirect beneficial ownership of 130,465 ordinary shares. The filing listed warrants exercisable at USD 5 for 6,122 ordinary shares. It also listed warrants exercisable at USD 5 for 2,083 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9Hp74n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620620862","title":"Regentis Biomaterials CFO Gon Ori files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620620862","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620620862?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:31","pubTimestamp":1773865880,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials filed an initial statement of beneficial ownership naming Ori Gon as chief financial officer. The filing reported an employee stock option for 84,951 shares of common stock. The option exercise price was USD 4.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLbc2Ns2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RGNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620039262","title":"Regentis Biomaterials Ltd. files Form 3 as Chief Accounting Officer Arie Gordashnikov reports no beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2620039262","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620039262?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:31","pubTimestamp":1773865875,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials filed an initial statement of beneficial ownership naming Arie Gordashnikov as Chief Accounting Officer. The filing reported that Gordashnikov beneficially owned no securities as of 03/18/2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1yhpZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620262718","title":"Regentis Biomaterials Director Pini Ben-Elazar Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620262718","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620262718?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:30","pubTimestamp":1773865856,"startTime":"0","endTime":"0","summary":"Regentis Biomaterials reported that director Pini Ben-Elazar filed an initial statement of beneficial ownership. Ben-Elazar reported direct ownership of 128,666 ordinary shares. He also reported an employee stock option for 39,295 shares with an exercise price of USD 0.01. Ben-Elazar reported warrants for 15,831 shares with an exercise price of USD 5.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regentis Biomaterials Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL5HK7wR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGNT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":57,"code":"91000000","status":"200"}]}}